, Russian Federation
E.N. Meshalkin National Medical Research Center, Novosibirsk, Russia
, Russian Federation
National Research Tomsk Polytechnic University, Tomsk, Russia
, Russian Federation
Siberian State Medical University, Tomsk, Russia
, Russian Federation
, Russian Federation
, Russian Federation
, Russian Federation
National Research Tomsk Polytechnic University, Tomsk, Russia
, Russian Federation
GRNTI 76.33 Гигиена и эпидемиология
GRNTI 76.03 Медико-биологические дисциплины
OKSO 31.06.2001 Клиническая медицина
OKSO 31.08.08 Радиология
OKSO 32.08.12 Эпидемиология
OKSO 14.04.02 Ядерные физика и технологии
BBK 534 Общая диагностика
BBK 51 Социальная гигиена и организация здравоохранения. Гигиена. Эпидемиология
TBK 5712 Медицинская биология. Гистология
TBK 5734 Медицинская радиология и рентгенология
TBK 6212 Радиоактивные элементы и изотопы. Радиохимия
TBK 5708 Гигиена и санитария. Эпидемиология. Медицинская экология
Purpose: To develop a functional stress-test with Dalargin used as a pharmacological stress agent and to study its diagnostic capabilities for quantifying the general and segmental systolic function of the left ventricle in patients with IHD using SPECT and echo methods. Material and methods: The study comprised 29 male patients with CHD-angina of 2-3 functional classes, studied on 15–25 days (on average 20 ± 2.8 days) after a large-focal myocardial infarction. A fractional step-wise injection of Dalargin was performed with step doses as 0.1 mg / kg (1 ml up to a total of 8 ml, with intervals of 90 seconds, for a total of 12 minutes), in a supine position. After each dose of Dalargin, blood pressure, heart rate, ECG were recorded, and an echocardiographic assessment of hemodynamic parameters and local contractility was carried out. At the peak of the effect of dalargin, 99mTc-Tetrofosmin was administered intravenously (370 – 540 MBq), followed by chest SPECT. Results: The optimal dose of dalargin for assessing the contractility of the LV was 0.3 mg/kg. From the data of myocardial perfusion SPECT, at dalargin test, the number of segments with normal regional blood supply increased statistically significantly from 56,0 % to 64,7 %, the number of hypoperfused segments decreased from 41.0% to 33.7% as compared to rest, and the number of non-perfused ones – from 3.0 % to 1.6 %. Spearman’s correlation coefficient between segmental contractility and local perfusion at the top dalargin inotropic effect was high and significant (R=0.67, p<0.01). The sensitivity and specificity of the pharmacological test with intravenous administration of dalargin for prediction of postoperative improvement of perfusion and contractility of the viable myocardium were: sensitivity 78.8 %, specificity 76.4 %, diagnostic accuracy 77.6 %. Conclusion. The use of the agonist of the μ - and δ-opioid receptors dalargin as a pharmacological stress-agent at perfusion SPECT and Stress Echocardiography to assess the contractile reserve of a dysfunctional viable myocardium is informative and appropriate. In patients with IHD who have suffered a myocardial infarction and are referred to myocardial revascularization, dalargin can be employed as an effective stress-agent for assessing the reserve of perfusion and contractility of dysfunctional left ventricular myocardium using perfusion SPECT and echocardiography.
SPECT, myocardial blood flow, functional reserve, dalargin, dalargin functional test, heart ultrasound
1. Maslov L.N., Lishmanov Yu.B., Naryzhnaya N.V. Opioidergicheskoe zveno morfofunkcional'nyh izmeneniy miokarda pri stresse i adaptacii. Tomsk: STT, 2003. 237 c.
2. Usov V.Yu., Sinicyn V.E., Obradovich V.A., Dragutinovich G.N., Efimova I.Yu., Plotnikov M.P., Karpov R.S. Ocenka reaktivnosti krovotoka golovnogo mozga s pomosch'yu adenozinovoy proby u pacientov so stenozom sonnyh arteriy po dannym MRT i emissionnoy tomografii s 99mTc-GMPAO // Vestnik rentgenologii i radiologii. 2000. №6. S. 4-9.
3. Aronov D.M., Lupanov V.P. Funkcional'nye proby v kardiologii. M.: MEDpress-inform, 2007.
4. Borisenko V.G., Gubareva E.A., Kade A.H. Reakcii miokarda na ishemiyu // Terapevticheskiy arhiv. 2010. T. 82, № 3. S. 64-67.
5. Bydanova S.S., Kir'yanova A.N., Leschinskiy L.A., Bydanov S.A. Klinicheskaya effektivnost' primeneniya analoga endogennyh neyropeptidov dalargina v kompleksnoy terapii ostrogo koronarnogo sindroma // Prakticheskaya medicina. 2004. №6. S. 22-23.
6. Griffin B., Topol' E. Kardiologiya. M.: Praktika, 2008.
7. Maslov L.N., Naryzhnaya N.V. Receptornye i signal'nye mehanizmy adapatacionnoy zaschity miokarda ot ishemicheski-reperfuzionnogo povrezhdeniya. Tomsk: Izd-vo Universiteta sistem upravleniya i radioelektroniki, 2018. 352 c.
8. Ansheles A.A., Sergienko I.V., Sergienko V.B., Denisenko-Kankiya E.I. Rezul'taty perfuzionnoy odnofotonnoy emissionnoy tomografii miokarda i dannyh koronarografii u pacientov s razlichnoy pretestovoy veroyatnost'yu ishemicheskoy bolezni serdca // Terapevticheskiy arhiv. 2020. T.92, №4. S. 30-36. DOI: 10.26442/00403660.2020.04.000549.
9. Migrino RQ, Xiaoguang Zhu, Pajewski N. Assessment of Segmental Myocardial Viability Using Regional 2-dimensional Strain Echocardiography // Journal of the American Society of Echocardiography. 2007. V.20, No.4. P. 342-351. DOI:10.1016/ j.echo.2006.09.011
10. Doncov A.V. Vozmozhnosti dalargina v lechenii bol'nyh IBS // Vestnik novyh medicinskih tehnologiy. 2012. T.19, №3. S. 159-161.
11. Lishmanov Yu.B., Makarova E.V., Chernov V.I., Vesnina Zh.V., Babokin V.E., Vorozhcova I.N., Buhovec I.L. Primenenie perfuzionnoy OFEKT serdca v sochetanii s rein'ekciey 199Tl v pokoe dlya diagnostiki miokardial'noy gibernacii // Medicinskaya radiologiya i radiacionnaya bezopasnost'. 2005. T.50, №.1. S. 62-67.
12. Saidova M.A. Sovremennye metody diagnostiki zhiznesposobnogo miokarda // Kardiologiya. 2005. №.9. S. 47-54.
13. Rosa S, Lauro C. The Clinical use of Stress Echocardiography in Ischemic Heart Disease // Cardiovascular Ultrasound. 2017. V.15. P.7, DOI 10.1186/s12947-017-0099-2.
14. Vorozhcova I.N., Buhovec I.L., Bezlyak V.V., Babokin V.E., Lishmanov Yu.B. Prognozirovanie gemodinamicheskoy effektivnosti hirurgicheskoy korrekcii hronicheskoy koronarnoy nedostatochnosti na osnovanii dannyh nagruzochnogo testirovaniya s nitroglicerinom // Kardiologiya. 2003. №6. S. 23-27.
15. Lishmanov Yu.B., Maslov L.N. Ishemicheskoe postkondicionirovanie serdca. Receptornye mehanizmy i vozmozhnost' klinicheskogo primeneniya // Kardiologiya. 2010. №6. S. 68-74.
16. Rybakova M.K., Alehin M.N., Mit'kov V.V. Ehokardiografiya: prakticheskoe rukovodstvo po ul'trazvukovoy diagnostike. M.: Vidar-M, 2008. 544 c.
17. Ross J. Myocardial Perfusion-Contraction Matching. Implications for Coronary Heart Disease and Hibernation // Circulation. 1991. V.83, P.1076-1083.
